Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGNX | AMGN | VRTX | REGN | GSK |
| Company | Regenxbio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 13.90 | 304.55 | 480.18 | 998.45 | 41.04 |
| High | 13.98 | 305.53 | 485.40 | 1,002.95 | 41.04 |
| Low | 13.22 | 300.89 | 478.51 | 992.22 | 41.04 |
| Last | 13.71 | 304.72 | 483.28 | 1,001.73 | 41.04 |
| Change | -0.37 | -0.30 | +0.24 | -1.22 | -0.25 |
| % Change | -2.63% | -0.10% | +0.05% | -0.12% | -0.61% |
| Volume | 674,300 | 1,992,800 | 1,253,800 | 250,800 | 15,946 |
| 20-Day Average Volume | 394,185 | 2,285,660 | 1,224,980 | 383,635 | 4,137,018 |
| Previous Close | 14.08 | 305.02 | 483.04 | 1,002.95 | 41.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.96 | 307.91 | 454.57 | 985.23 | 43.65 |
| 20-Day Raw Stochastic | 13.50% | 35.57% | 95.08% | 77.60% | 9.79% |
| 20-Day Relative Strength | 34.92% | 55.22% | 74.05% | 61.69% | 40.81% |
| Weighted Alpha | -42.44 | +29.62 | +44.70 | +29.65 | +15.16 |
| Today's Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 40% Sell | 56% Buy | 56% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.11% since 06/03/24 | -0.88% since 06/03/24 | +2.79% since 06/03/24 | +1.24% since 06/03/24 | -0.75% since 06/04/24 |
| Low | 13.22 on 06/10/24 | 300.89 on 06/10/24 | 467.37 on 06/04/24 | 986.64 on 06/04/24 | 40.94 on 06/07/24 |
| High | 14.77 on 06/05/24 | 310.92 on 06/04/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 42.44 on 06/05/24 |
| 1-Month | |||||
| %Chg | -11.20% since 05/10/24 | -1.75% since 05/10/24 | +14.31% since 05/10/24 | +2.87% since 05/10/24 | -8.94% since 05/10/24 |
| Low | 13.22 on 06/10/24 | 295.49 on 05/30/24 | 422.44 on 05/14/24 | 952.30 on 05/30/24 | 40.51 on 06/03/24 |
| High | 16.85 on 05/15/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -39.74% since 03/08/24 | +11.31% since 03/08/24 | +16.85% since 03/08/24 | +3.40% since 03/08/24 | -4.38% since 03/11/24 |
| Low | 13.22 on 06/10/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 23.57 on 03/11/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -29.98% since 12/08/23 | +13.23% since 12/08/23 | +38.02% since 12/08/23 | +19.23% since 12/08/23 | +12.84% since 12/11/23 |
| Low | 11.83 on 02/02/24 | 260.68 on 04/19/24 | 351.44 on 12/11/23 | 838.44 on 12/11/23 | 35.87 on 12/15/23 |
| High | 28.80 on 03/05/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 675,300 | 163,462,464 | 124,711,856 | 110,376,608 | 85,571,048 |
| Shares Outstanding, K | 49,256 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 90,240,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -263,490,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 15,620,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -63,330,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.34 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.38 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/08/24 | 08/01/24 | 05/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.37 | 32.07 | 27.03 | 10.20 |